ATE136222T1 - Heilmittel und verfahren zur inhibierung der vaskularisierung von tumoren - Google Patents

Heilmittel und verfahren zur inhibierung der vaskularisierung von tumoren

Info

Publication number
ATE136222T1
ATE136222T1 AT90914867T AT90914867T ATE136222T1 AT E136222 T1 ATE136222 T1 AT E136222T1 AT 90914867 T AT90914867 T AT 90914867T AT 90914867 T AT90914867 T AT 90914867T AT E136222 T1 ATE136222 T1 AT E136222T1
Authority
AT
Austria
Prior art keywords
remedies
tumors
methods
inhibiting vascularization
vascularization
Prior art date
Application number
AT90914867T
Other languages
English (en)
Inventor
Carl G Hellerqvist
Original Assignee
Univ Vanderbilt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Vanderbilt filed Critical Univ Vanderbilt
Application granted granted Critical
Publication of ATE136222T1 publication Critical patent/ATE136222T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT90914867T 1989-09-25 1990-09-13 Heilmittel und verfahren zur inhibierung der vaskularisierung von tumoren ATE136222T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/411,674 US5010062A (en) 1989-09-25 1989-09-25 Therapeutic agent and method of inhibiting vascularization of tumors

Publications (1)

Publication Number Publication Date
ATE136222T1 true ATE136222T1 (de) 1996-04-15

Family

ID=23629867

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90914867T ATE136222T1 (de) 1989-09-25 1990-09-13 Heilmittel und verfahren zur inhibierung der vaskularisierung von tumoren

Country Status (10)

Country Link
US (1) US5010062A (de)
EP (1) EP0445280B1 (de)
JP (1) JPH0662426B2 (de)
AT (1) ATE136222T1 (de)
AU (1) AU626733B2 (de)
CA (1) CA2042032C (de)
DE (1) DE69026371T2 (de)
DK (1) DK0445280T3 (de)
ES (1) ES2087915T3 (de)
WO (1) WO1991004048A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811403A (en) * 1996-09-30 1998-09-22 Vanderbilt University Polysaccharide toxin from Group B β-hemolytic Streptococcus (GBS) having improved purity
US5858991A (en) * 1997-01-29 1999-01-12 Vanderbilt University Facilitation of wound healing with CM101/GBS toxin
US6670337B1 (en) 1998-01-29 2003-12-30 Yeda Reaearch And Development Co., Ltd. Facilitation of wound healing with CM101/GBS toxin
US5981508A (en) * 1997-01-29 1999-11-09 Vanderbilt University Facilitation of repair of neural injury with CM101/GBS toxin
US6028060A (en) * 1997-01-29 2000-02-22 Vanderbilt University Treatment of chronic inflammatory diseases with CM101/GBS toxin
US6756361B1 (en) * 1997-10-14 2004-06-29 Nabi Enterococcus antigens and vaccines
US8609614B2 (en) * 1998-07-22 2013-12-17 Vanderbilt University GBS toxin receptor compositions and methods of use
US6803448B1 (en) * 1998-07-22 2004-10-12 Vanderbilt University GBS toxin receptor
US20040122011A1 (en) * 1998-12-23 2004-06-24 Pharmacia Corporation Method of using a COX-2 inhibitor and a TACE inhibitors as a combination therapy
EP1198246B1 (de) * 2000-02-02 2010-04-28 Vanderbilt University Verfahren zur vorbeugung und linderung angiogener erkrankungen durch impfung mit dem rezeptor für gbs-toxin (cm101)
WO2004062597A2 (en) * 2003-01-09 2004-07-29 The Trustees Of The University Of Pennsylvania Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS557014A (en) * 1978-06-29 1980-01-18 Chugai Pharmaceut Co Ltd Antitumor agent and its preparation
US4522803A (en) * 1983-02-04 1985-06-11 The Liposome Company, Inc. Stable plurilamellar vesicles, their preparation and use
US4882317A (en) * 1984-05-10 1989-11-21 Merck & Co., Inc. Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers and methods of preparing such polysaccharides and conjugataes and of confirming covalency
NZ222192A (en) * 1986-10-20 1991-03-26 Kanto Ishi Pharma Co Ltd Glycolipid containing n-glycolylneuraminic acid, and preparation thereof
US4939083A (en) * 1986-10-30 1990-07-03 La Jolla Cancer Research Foundation Carbohydrate specific to chronic myelogenous leukemia granulocytes
US4895838A (en) * 1988-03-09 1990-01-23 Trustees Of Boston University Method for provoking angiogenesis by administration of angiogenically active oligosaccharides

Also Published As

Publication number Publication date
DE69026371T2 (de) 1996-08-01
US5010062A (en) 1991-04-23
CA2042032C (en) 1995-10-10
DE69026371D1 (de) 1996-05-09
DK0445280T3 (da) 1996-07-08
EP0445280A4 (en) 1993-05-05
AU6513590A (en) 1991-04-18
JPH0662426B2 (ja) 1994-08-17
EP0445280A1 (de) 1991-09-11
CA2042032A1 (en) 1991-03-26
AU626733B2 (en) 1992-08-06
JPH04501870A (ja) 1992-04-02
ES2087915T3 (es) 1996-08-01
WO1991004048A1 (en) 1991-04-04
EP0445280B1 (de) 1996-04-03

Similar Documents

Publication Publication Date Title
DE69428523D1 (de) Verfahren zur behandlung von gemüts- oder geisteskrankheiten und von gemüts- oder geisteskrankheiten, die von anfällen begleitet sind
DK0380230T3 (da) Immunogene sammensætninger mod gastrin-peptider
ATE136222T1 (de) Heilmittel und verfahren zur inhibierung der vaskularisierung von tumoren
FI941133A0 (fi) Koostumus ja menetelmä hepatiitti C:n hoitamiseksi
ATE270553T1 (de) Anwendung von 1,2,4-benzotriazinoxiden zur herstellung eines arzneimittels zur behandlung von tumoren
NO974275D0 (no) Fremgangsmåte for behandling av tumorer
ATE132040T1 (de) Verwendung von phospholipiden zur herstellung eines topischen arzneimittels zur beinflussung des serumcholesterinspiegels
BE900650A (fr) Composition d'endotoxine detoxifiee raffinee et d'un extrait d'un microorganisme soluble dans la pyridine.
FI933193A0 (fi) Behandling av neoplastisk sjukdom med interleukin-10
FI895141A0 (fi) Kelatmedel med orto-ligerande funktionalitet och deras komplexer.
DE3785157D1 (de) Verfahren zur herstellung von toxoid.
DE69327248D1 (de) Verfahren zur behandlung des symptomenkomplexes des prämenstruellen syndroms mit vitamin d oder vitamin d und calcium
ATE308994T1 (de) Gebrauch von antikörpern zur verhinderung von auswirkungen hervorgerufen durch grampositive- und myko-bakterien
ATE125709T1 (de) Verwendung von ifn-gamma zur herstellung einer pharmazeutischen zusammensetzung für die behandlung von atl.
DE69818809D1 (de) Verfahren zur behandlung von narbengewebe
ATE245991T1 (de) Behandlung chronischer entzündungskrankheiten mit cm101/gbs-toxin
ES460621A1 (es) Procedimiento de sintesis de n-(1'-alil-2'-pirrolidilmetil)-2,3-dimetoxi-5-sulfamoilbenzamida.
ZA837972B (en) Method of analgesic treatment and pharmaceutical compositions
MX9200755A (es) Tratamiento de carcinoma pulmonar de celulas no pequeñas.
ATE167398T1 (de) Behandlungsverfahren für therapiewiderstehende schizophrenie mit amperozide
BR9708037A (pt) Método para o tratamento de abuso de substância
EA199800822A1 (ru) Способ лечения избыточной агрессии
DE69228112D1 (de) Verfahren zur verbesserung des gedächtnisses und zur steigerung der lebensqualitet
ATE186401T1 (de) Verfahren zur bestimmung der wirksamkeit und verträglichkeit eines xenogenen stoffes auf einen organismus
RU5065975A (ru) Способ лечения злокачественных опухолей

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee